Search results for “Borderline resectable” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 70 patents, we discovered top 19 key players by total patent application. AstraZeneca Pharmaceutical Co., Ltd., Bristol Myers Squibb Co., X4 Pharmaceuticals, Inc. are dominant in this area. They take 45.71% of the total patent filing.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 14
Bristol Myers Squibb Co.
New York, United States
Patent: 9
X4 Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 9
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 6
Genentech, Inc.
California, United States
Patent: 5
Novartis AG
Basel-Stadt, Switzerland
Patent: 4
Teva Pharmaceutical Industries Ltd.
Israel
Patent: 3
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 2
SciClone Pharmaceuticals LLC
California, United States
Patent: 2
STARTUP
ImmunSYS, Inc.
United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
ImmunSYS, Inc.
United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 71 patents applied in the last 5 years. We discover 22 most active companies in this area. The fast-growing AstraZeneca Pharmaceutical Co., Ltd., Bristol Myers Squibb Co., X4 Pharmaceuticals, Inc. take 45.07% of patent filing during this period.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 14
Bristol Myers Squibb Co.
New York, United States
Patent: 9
X4 Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 9
University of Rochester
New York, United States
Patent: 6
Novartis AG
Basel-Stadt, Switzerland
Patent: 4
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 3
Zhongshan Hospital Fudan University
Shanghai Shi, China
Patent: 2
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 2
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 2
Institut Jean Paoli & Irene Calmettes
France
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 71 patents in last 5 years, we discover 19 new entrants. AstraZeneca Pharmaceutical Co., Ltd., Bristol Myers Squibb Co., X4 Pharmaceuticals, Inc. are the most active new entrants in this area.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 14
Bristol Myers Squibb Co.
New York, United States
Patent: 9
X4 Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 9
University of Rochester
New York, United States
Patent: 6
Novartis AG
Basel-Stadt, Switzerland
Patent: 4
Zhongshan Hospital Fudan University
Shanghai Shi, China
Patent: 2
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 2
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 2
Institut Jean Paoli & Irene Calmettes
France
Patent: 2
Centre National De La Recherche Scientif
France
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 20 patents, we discovered top 3 universities and scientific research institutions by total patent application.
University of Rochester
New York, United States
Patent: 6
Université d'Aix-Marseille
France
Patent: 2
Technical University of Cluj Napoca
Cluj, Romania
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: